- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips unveils new CT and PET/CT platforms
Philips is adding to its portfolio a new line of CT scanners and a new line of PET/CTs based on dose-saving technologies. Ingenuity CT will displace Philips’ Brilliance line of CTs in configurations up to 128 slices; the Ingenuity TF PET/CT will displace the company’s Gemini platform of PET/CTs. Philips will not stop making these older models, but will feature them in its product portfolio as alternatives to the latest releases.
Philips is adding to its portfolio a new line of CT scanners and a new line of PET/CTs based on dose-saving technologies. Ingenuity CT will displace Philips’ Brilliance line of CTs in configurations up to 128 slices; the Ingenuity TF PET/CT will displace the company’s Gemini platform of PET/CTs. Philips will not stop making these older models, but will feature them in its product portfolio as alternatives to the latest releases.
The Ingenuity CT features iDose4, the company’s next-generation iterative reconstruction technique, which allows operators to choose vastly increased spatial resolution, substantially less dose, or some of both. Various points along the scale will allow a blend of the two. For example, scans at equivalent diagnostic quality but with up to 80% less dose, spatial resolution improved by as much as 35% with up to 50% less dose, or simply spatial resolution improved by up to 68%.
An added feature of the new CT platform is SyncRight, which leverages enhanced communications between the scanner and injector, creating consistent image quality from patient to patient and enabling up to a 15% reduction in injected contrast per patient. This promises better visualization of vascular structures, which will result in fewer repeat exams, according to the company.
The new IngenuityCT anchors the Ingenuity TF PET/CT system, which also improves on its Gemini predecessor’s time-of-flight (TOF) technology with Astonish TF, the next evolution of TOF. Astonish TF shows 50% improved contrast resolution, according to Philips, while maintaining quantitative accuracy with up to four times faster reconstruction compared with previous-generation systems.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
